285 related articles for article (PubMed ID: 16305339)
21. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
Wieczorek Z; Słoń J; Siemion IZ
Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
[TBL] [Abstract][Full Text] [Related]
22. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
23. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.
Wang J; Tong X; Li P; Cao H; Su W
J Ethnopharmacol; 2012 Feb; 139(3):788-95. PubMed ID: 22212503
[TBL] [Abstract][Full Text] [Related]
24. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Gill HK; Liew FY
Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of bioactive fraction of Sphaeranthus indicus Linn. against cyclophosphamide induced suppression of humoral immunity in mice.
Bafna AR; Mishra SH
J Ethnopharmacol; 2006 Apr; 104(3):426-9. PubMed ID: 16289412
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive activity of Semen Persicae ethanol extract on specific antibody and cellular response to ovalbumin in mice.
Zhang YB; Qin F; Sun HX
Chem Biodivers; 2006 Sep; 3(9):967-74. PubMed ID: 17193328
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
Otterness IG; Chang YH
Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
[TBL] [Abstract][Full Text] [Related]
28. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
29. Lactoferrin as an Adjuvant for the Generation of Delayed Type Hypersensitivity to Orally Administered Antigen.
Zimecki M; Kruzel ML; Hwang SA; Wilk KM; Actor JK
Ann Clin Lab Sci; 2021 May; 51(3):359-367. PubMed ID: 34162566
[TBL] [Abstract][Full Text] [Related]
30. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
Marusić M
Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
[TBL] [Abstract][Full Text] [Related]
31. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
Zimecki M; Wieczorek Z
Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
[TBL] [Abstract][Full Text] [Related]
32. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
33. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
Naparstek E; Ohana M; Greenberger JS; Slavin S
Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
[TBL] [Abstract][Full Text] [Related]
34. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
35. Immune function in cyclophosphamide-treated mice is restored by the T-cell-tropic isoxazole derivative R-13.
Zimecki M; Artym J; Kocięba M; Obmińska-Mrukowicz B; Mączyński M; Ryng S
J Immunotoxicol; 2015; 12(4):322-9. PubMed ID: 26269136
[TBL] [Abstract][Full Text] [Related]
36. A new method for tolerance induction: busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow.
Nagahama T; Sugiura K; Lee S; Morita H; Adachi Y; Kwon AH; Kamiyama Y; Ikehara S
Stem Cells; 2001; 19(5):425-35. PubMed ID: 11553851
[TBL] [Abstract][Full Text] [Related]
37. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
Buurman WA; van Bruggen I
Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kruzel ML
Inflamm Res; 2004 Jul; 53(7):292-6. PubMed ID: 15241563
[TBL] [Abstract][Full Text] [Related]
39. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
